Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Odronextamab plus chemo safe as DLBCL treatment, with promising efficacy
Odronextamab plus chemo safe as DLBCL treatment, with promising efficacy
16 Jan 2026
Maternal asthma may raise congenital heart defect risk in offspring
Maternal asthma may raise congenital heart defect risk in offspring
15 Jan 2026 bởiStephen Padilla

Asthma and allergic tendency in mothers appear to elevate the risk of congenital heart defect (CHD) in their children, suggests a study, noting that nonallergic asthma also contributes to such risk.

Maternal asthma may raise congenital heart defect risk in offspring
15 Jan 2026
EPIK-B5 supports alpelisib plus fulvestrant for HR+, HER2– ABC
EPIK-B5 supports alpelisib plus fulvestrant for HR+, HER2– ABC
15 Jan 2026